• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与系统性红斑狼疮相关的死亡率概况:多病因死亡分析。

Mortality profile related to systemic lupus erythematosus: a multiple cause-of-death analysis.

机构信息

Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil.

出版信息

J Rheumatol. 2012 Mar;39(3):496-503. doi: 10.3899/jrheum.110241. Epub 2012 Jan 15.

DOI:10.3899/jrheum.110241
PMID:22247362
Abstract

OBJECTIVE

To analyze the mortality profile related to systemic lupus erythematosus (SLE) in the state of São Paulo, Brazil.

METHODS

For the 1985-2007 period, we analyzed all death certificates (n = 4815) on which SLE was listed as an underlying (n = 3133) or non-underlying (n = 1682) cause of death. We evaluated sex, age, and the causes of death, comparing the first and last 5 years of the period, as well as determining the observed/expected death ratio (O/E ratio).

RESULTS

For SLE as an underlying cause, the mean age at death was 35.77 years (SD 15.12) and the main non-underlying causes of death were renal failure, circulatory system diseases, pneumonia, and septicemia. Over the period, the proportional mention of infectious causes and circulatory system diseases increased, whereas renal diseases decreased. For SLE as a non-underlying cause of death, the most common underlying causes of death were circulatory, respiratory, genitourinary, and digestive system diseases, and certain infections. The overall death O/E ratio was > 1 for renal failure, tuberculosis, septicemia, pneumonia, and digestive system diseases, as well as for circulatory system diseases at < 50 years of age, particularly acute myocardial infarct.

CONCLUSION

Unlike in developed countries, renal failure and infectious diseases are still the most frequent causes of death. The increase in SLE deaths associated with infection, especially pneumonia and septicemia, is worrisome. The judicious use of immunosuppressive therapy together with vigorous treatment of cardiovascular comorbidities is crucial to the successful management of SLE and to improving survival of patients with SLE.

摘要

目的

分析巴西圣保罗州系统性红斑狼疮(SLE)相关死亡率情况。

方法

1985 年至 2007 年期间,我们分析了所有死亡证明(n=4815),其中 SLE 被列为根本(n=3133)或非根本(n=1682)死因。我们评估了性别、年龄和死因,并比较了该期间的前 5 年和后 5 年,以及确定了观察到/预期死亡比(O/E 比)。

结果

SLE 作为根本死因时,平均死亡年龄为 35.77 岁(SD15.12),主要的非根本死因是肾衰竭、循环系统疾病、肺炎和败血症。在此期间,传染性病因和循环系统疾病的比例有所增加,而肾脏疾病则有所减少。SLE 作为非根本死因时,最常见的根本死因是循环系统、呼吸系统、泌尿生殖系统和消化系统疾病以及某些感染。肾衰竭、结核病、败血症、肺炎和消化系统疾病以及 50 岁以下循环系统疾病的总死亡率 O/E 比>1,特别是急性心肌梗死。

结论

与发达国家不同,肾衰竭和传染病仍然是最常见的死亡原因。与感染相关的 SLE 死亡增加,尤其是肺炎和败血症,令人担忧。明智地使用免疫抑制疗法并积极治疗心血管合并症,对于 SLE 的成功管理和提高 SLE 患者的生存率至关重要。

相似文献

1
Mortality profile related to systemic lupus erythematosus: a multiple cause-of-death analysis.与系统性红斑狼疮相关的死亡率概况:多病因死亡分析。
J Rheumatol. 2012 Mar;39(3):496-503. doi: 10.3899/jrheum.110241. Epub 2012 Jan 15.
2
Mortality study in Puerto Ricans with systemic lupus erythematosus.
P R Health Sci J. 2000 Dec;19(4):335-9.
3
Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis.瑞典南部系统性红斑狼疮的发病率研究:年龄增长、肾脏表现频率降低及预后良好。
J Rheumatol. 2000 Mar;27(3):685-91.
4
A Study of Multiple Causes of Death in Rheumatoid Arthritis.类风湿关节炎多种死因的研究
J Rheumatol. 2015 Dec;42(12):2221-8. doi: 10.3899/jrheum.150166. Epub 2015 Oct 15.
5
Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death.系统性红斑狼疮的死亡率研究。单中心研究结果。I. 死亡原因。
J Rheumatol. 1995 Jul;22(7):1259-64.
6
Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964-95.尽管系统性红斑狼疮患者的预后有所改善,但心血管疾病仍是一个危险因素:一项基于瑞典人群的1964 - 1995年研究结果
J Rheumatol. 2004 Apr;31(4):713-9.
7
Survival rate among Thai systemic lupus erythematosus patients in the era of aggressive treatment.泰国系统性红斑狼疮患者在强化治疗时代的生存率。
Int J Rheum Dis. 2011 Oct;14(4):353-60. doi: 10.1111/j.1756-185X.2011.01639.x. Epub 2011 Jul 29.
8
Survival analysis and prognostic indicators of systemic lupus erythematosus in Pakistani patients.巴基斯坦系统性红斑狼疮患者的生存分析及预后指标
Lupus. 2009 Aug;18(9):848-55. doi: 10.1177/0961203309103410.
9
Prognostic indicators of hospitalized patients with systemic lupus erythematosus: a large retrospective multicenter study in China.中国一项大型回顾性多中心研究:系统性红斑狼疮住院患者的预后指标。
J Rheumatol. 2011 Jul;38(7):1289-95. doi: 10.3899/jrheum.101088. Epub 2011 Apr 1.
10
Causes of death in Korean patients with systemic lupus erythematosus: a single center retrospective study.韩国系统性红斑狼疮患者的死因:一项单中心回顾性研究。
Clin Exp Rheumatol. 1999 Sep-Oct;17(5):539-45.

引用本文的文献

1
Defining cause of death in a contemporary cohort with ANCA-associated vasculitis (AAV): A comparison of electronic health record and death certificate data.确定当代抗中性粒细胞胞浆抗体相关性血管炎(AAV)队列中的死因:电子健康记录与死亡证明数据的比较。
Semin Arthritis Rheum. 2025 Feb;70:152609. doi: 10.1016/j.semarthrit.2024.152609. Epub 2024 Dec 19.
2
Mortality in a cohort of Egyptian systemic lupus erythematosus patients: A comparison with African, Arabic, and Mediterranean studies.一组埃及系统性红斑狼疮患者的死亡率:与非洲、阿拉伯和地中海地区研究的比较。
Arch Rheumatol. 2022 Dec 30;38(3):468-476. doi: 10.46497/ArchRheumatol.2023.9860. eCollection 2023 Sep.
3
Novel Imaging Approaches to Cardiac Manifestations of Systemic Inflammatory Diseases: JACC Scientific Statement.
新型影像学方法在系统性炎症疾病心脏表现中的应用:美国心脏病学会科学声明
J Am Coll Cardiol. 2023 Nov 28;82(22):2128-2151. doi: 10.1016/j.jacc.2023.09.819.
4
An Examination of Infection Incidence and Management in Systemic Lupus Erythematosus Patients: A Five-Year Review from a Saudi Arabian Center.系统性红斑狼疮患者感染发生率及管理情况分析:来自沙特阿拉伯某中心的五年回顾
Med Sci Monit. 2023 Aug 30;29:e941277. doi: 10.12659/MSM.941277.
5
Generic and disease-adapted cardiovascular risk scores as predictors of atherosclerosis progression in SLE.通用型和疾病适应型心血管风险评分作为 SLE 患者动脉粥样硬化进展的预测指标。
Lupus Sci Med. 2023 Mar;10(1). doi: 10.1136/lupus-2022-000864.
6
The Behaviour of Serum Survivin in Patients With Lupus Nephritis.狼疮性肾炎患者血清生存素的行为
Biomark Insights. 2022 Oct 22;17:11772719221131470. doi: 10.1177/11772719221131470. eCollection 2022.
7
Risk of Severe SARS-CoV-2 Infection in Patients with Autoimmune Rheumatic Diseases in Qatar: A Cohort Matched Study.卡塔尔自身免疫性风湿病患者感染重症严重急性呼吸综合征冠状病毒2的风险:一项队列匹配研究。
Qatar Med J. 2022 Jun 20;2022(3):24. doi: 10.5339/qmj.2022.24. eCollection 2022.
8
The landscape of systemic lupus erythematosus in Brazil: An expert panel review and recommendations.巴西系统性红斑狼疮的研究现状:专家小组综述及建议
Lupus. 2021 Sep;30(10):1684-1695. doi: 10.1177/09612033211030008. Epub 2021 Jul 13.
9
The risk of infections in adult patients with systemic lupus erythematosus: systematic review and meta-analysis.成人系统性红斑狼疮患者感染风险:系统评价和荟萃分析。
Rheumatology (Oxford). 2021 Jan 5;60(1):60-72. doi: 10.1093/rheumatology/keaa478.
10
First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, )-Pan-American League of Associations of Rheumatology (PANLAR).首个拉丁美洲系统性红斑狼疮治疗临床实践指南:拉丁美洲狼疮研究组(GLADEL)-泛美风湿病学会联盟(PANLAR)。
Ann Rheum Dis. 2018 Nov;77(11):1549-1557. doi: 10.1136/annrheumdis-2018-213512. Epub 2018 Jul 25.